Therapeutic Asset Ratings

622 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Hydroxychloroquine Breast Cancer	University of Arizona	P2	CCC (53)
HYROGEN PEROXIDE Breast Cancer	Institute of Cancer Research, United Kingdom	P2	CCC (53)
Losartan Breast Cancer	Massachusetts General Hospital	P2	CCC (53)
Nicotine Breast Cancer	Institut Cancerologie de l'Ouest	P2	CCC (53)
Superparamagnetic Iron Oxide Breast Cancer	Vastra Gotaland Region	P2	CCC (53)
Trebananib Breast Cancer	QuantumLeap Healthcare Collaborative	P2	CCC (53)
Venetoclax Breast Cancer	Dana-Farber Cancer Institute	P2	CCC (53)
(Z)-Endoxifen Breast Cancer	Robert Bosch Gesellschaft für Medizinische Forschung mbH (RBMF)	P2	CCC (53)
cc-5013 Breast Cancer	Second Affiliated Hospital, School of Medicine, Zhejiang University	P2/3	CCC (53)
Clindamycin Breast Cancer	Cairo University	P3	CCC (52)
Duloxetine Breast Cancer	European Organisation for Research and Treatment of Cancer - EORTC	P3	CCC (52)
FES F-18 Breast Cancer	University of Washington	P3	CCC (52)
Sonovue Breast Cancer	Milton S. Hershey Medical Center	P3	CCC (52)
Atropine Breast Cancer	MedSIR	P2	CCC (52)
Clonidine Breast Cancer	Tufts Medical Center	P2	CCC (52)
Zactima Breast Cancer	UNICANCER	P2	CCC (52)
Perflutren Lipid Microsphere Intravenous Suspension Breast Cancer	UNC Lineberger Comprehensive Cancer Center	P2/3	CCC (52)
Sonazoid Breast Cancer	The Netherlands Cancer Institute	P2/3	CCC (52)
coq10 Breast Cancer	Damanhour University	P2	CCC (51)
IMMUNOGLOBULIN G1 (HUMAN-RAT MONOCLONAL CAMPATH-1H .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD52), DISULFIDE WITH HUMAN-RAT MONOCLONAL CAMPATH-1H LIGHT CHAIN, DIMER Breast Cancer	Institut du Cancer de Montpellier - Val d'Aurelle	P2	CCC (51)
Pexidartinib Breast Cancer	Hope Rugo, MD	P2	CCC (51)
Bpi-16350 Breast Cancer	Betta Pharmaceuticals Co., Ltd.	P3	CCC (50)
Ddac-Mini Ctc Breast Cancer	The Netherlands Cancer Institute	P3	CCC (50)
Filgrastine Breast Cancer	Blau Farmaceutica S.A.	P3	CCC (50)
Glsi-100 Breast Cancer	Greenwich LifeSciences, Inc.	P3	CCC (50)

Showing 201 to 225 of 622 assets

PreviousPage 9 of 25Next